Venkata Subramanian Krishnaraju
Overview
Explore the profile of Venkata Subramanian Krishnaraju including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kaur N, Kumar R, Rana N, Krishnaraju V, Mittal B
Indian J Nucl Med
. 2022 Aug;
37(2):147-153.
PMID: 35982818
Objective: radioactivity measurement of positron emission tomography/computed tomography (PET/CT)-guided biopsy tissue specimen to check the viable tumor sampling and predict the nature of the biopsied lesion. Materials And Methods: We...
12.
Tanigassalam S, Krishnaraju V, Sood A, Aggarwal P, Bhattacharya A, Bansal D, et al.
J Nucl Med Technol
. 2022 Feb;
PMID: 35197271
Fanconi anemia (FA) is a genetic disease associated with the risk of different congenital malformations, bone marrow failure, and predisposition to cancer. Congenital abnormalities of the kidney and urinary tract...
13.
Mathur Y, Krishnaraju V, Singh H, Kumar R, Dutta P
Clin Nucl Med
. 2022 Feb;
47(5):e408-e410.
PMID: 35195580
Von Hippel-Lindau syndrome is an autosomal dominant disorder. It is associated with a spectrum of benign and malignant tumors, including pancreatic and adrenal neuroendocrine tumors, renal cell carcinoma, and hemangioblastomas...
14.
Kumar R, Singh S, Mittal B, Vadi S, Kakkar N, Singh H, et al.
Radiology
. 2022 Feb;
303(2):392-398.
PMID: 35191735
Background Transrectal US-guided biopsy with or without MRI fusion is performed for diagnosing prostate cancer (PCa) but has limitations. Gallium 68 (Ga) prostate-specific membrane antigen (PSMA) PET/CT-guided targeted biopsy has...
15.
Subramanian K, Krishnaraju V, Kumar R, Bhadada S, Mittal B
Indian J Nucl Med
. 2022 Feb;
36(4):447-448.
PMID: 35125769
Parathyroid adenoma sometimes present in ectopic location and may pose a difficulty in both diagnosis and localization. We report a case of a young lady suspected to have neuroendocrine tumor...
16.
Krishnaraju V, Upadhyay R, Sood A, Bhattacharya A, Mittal B
Asia Ocean J Nucl Med Biol
. 2022 Jan;
10(1):53-56.
PMID: 35083351
Hypercalcemia is a clinical condition characterized by elevated circulating serum calcium levels either due to raised parathyroid hormone in hyperparathyroidism or due to secondary causes of hypercalcemia without elevated parathyroid...
17.
Krishnaraju V, Nahar Saikia U, Bhadada S, Mittal B, Sood A, Singh P, et al.
Endocr Pract
. 2021 Jun;
27(6):614-620.
PMID: 34120702
Objective: Functional cystic lesion of the parathyroid gland is a rare cause of primary hyperparathyroidism (PHPT). They have been postulated to arise from the hemorrhage and cystic degeneration in the...
18.
Krishnaraju V, Kumar R, Sood A, Shukla J, Subramanian K, Kakkar N, et al.
Nucl Med Mol Imaging
. 2021 Jun;
55(3):141-145.
PMID: 34109009
Chondrosarcoma is a cartilaginous tumor of mesenchymal origin. The histology and grade of the tumor determine the chances of relapse and survival. These tumors usually respond poorly to chemo-radiotherapy in...
19.
Bollampally N, Krishnaraju V, Sood A, Aggarwal S, Mittal B
Indian J Nucl Med
. 2021 May;
36(1):78-79.
PMID: 34040306
Osteogenic sarcoma is an aggressive malignant bone tumor arising from primitive mesenchymal bone-forming cells. Ossification is the characteristic feature of the metastases in osteosarcoma which aids their detection on Tc-MDP...
20.
Krishnaraju V, Singh H, Kumar R, Sharma S, Mittal B, Bhattacharya A
Br J Radiol
. 2021 May;
94(1122):20201204.
PMID: 33979202
Localizing the sites of infection in the body is possible in nuclear medicine using a variety of radiopharmaceuticals that target different components of the infective and inflammatory cascade. Gamma(γ)-emitting agents...